Home / Publications / Synthesis, structure and cytotoxicity of a zinc(II) bromide complex with caffeine

Synthesis, structure and cytotoxicity of a zinc(II) bromide complex with caffeine

Nataliya Samuilovna Rukk 1
Nataliya Samuilovna Rukk
, 
Ludmila G Kuz'mina 2
Ludmila G Kuz'mina
, 
Galina Anatol'evna Davydova 3
Galina Anatol'evna Davydova
,  , 
Vasilii Mikhaylovich Retivov 4
Vasilii Mikhaylovich Retivov
, 
Svetlana Konstantinovna Belus 4
Svetlana Konstantinovna Belus
, 
Evgeniya Igorevna Kozhukhova 4
Evgeniya Igorevna Kozhukhova
, 
Alexander Evgen'evich Barmashov 5
Alexander Evgen'evich Barmashov
, 
Alexey A Khrulev 1
Alexey A Khrulev
, 
Mariya Aleksandrovna Simonova 3
Mariya Aleksandrovna Simonova
, 
Valeriya N Krasnoperova 1
Valeriya N Krasnoperova
10.1016/j.mencom.2019.11.011
Published 2019-11-01
Communication , Volume 29, Issue 6, 640-642
9
Share
Cite this
GOST
 | 
Cite this
GOST Copy
Rukk N. S. et al. Synthesis, structure and cytotoxicity of a zinc(II) bromide complex with caffeine // Mendeleev Communications. 2019. Vol. 29. No. 6. pp. 640-642.
GOST all authors (up to 50) Copy
Rukk N. S., Kuz'mina L. G., Davydova G. A., Buzanov G. A., Retivov V. M., Belus S. K., Kozhukhova E. I., Barmashov A. E., Khrulev A. A., Simonova M. A., Krasnoperova V. N. Synthesis, structure and cytotoxicity of a zinc(II) bromide complex with caffeine // Mendeleev Communications. 2019. Vol. 29. No. 6. pp. 640-642.
RIS
 | 
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.mencom.2019.11.011
UR - https://mendcomm.colab.ws/publications/10.1016/j.mencom.2019.11.011
TI - Synthesis, structure and cytotoxicity of a zinc(II) bromide complex with caffeine
T2 - Mendeleev Communications
AU - Rukk, Nataliya Samuilovna
AU - Kuz'mina, Ludmila G
AU - Davydova, Galina Anatol'evna
AU - Buzanov, Grigory Alekseevich
AU - Retivov, Vasilii Mikhaylovich
AU - Belus, Svetlana Konstantinovna
AU - Kozhukhova, Evgeniya Igorevna
AU - Barmashov, Alexander Evgen'evich
AU - Khrulev, Alexey A
AU - Simonova, Mariya Aleksandrovna
AU - Krasnoperova, Valeriya N
PY - 2019
DA - 2019/11/01
PB - Mendeleev Communications
SP - 640-642
IS - 6
VL - 29
ER -
BibTex
 | 
Cite this
BibTex (up to 50 authors) Copy
@article{2019_Rukk,
author = {Nataliya Samuilovna Rukk and Ludmila G Kuz'mina and Galina Anatol'evna Davydova and Grigory Alekseevich Buzanov and Vasilii Mikhaylovich Retivov and Svetlana Konstantinovna Belus and Evgeniya Igorevna Kozhukhova and Alexander Evgen'evich Barmashov and Alexey A Khrulev and Mariya Aleksandrovna Simonova and Valeriya N Krasnoperova},
title = {Synthesis, structure and cytotoxicity of a zinc(II) bromide complex with caffeine},
journal = {Mendeleev Communications},
year = {2019},
volume = {29},
publisher = {Mendeleev Communications},
month = {Nov},
url = {https://mendcomm.colab.ws/publications/10.1016/j.mencom.2019.11.011},
number = {6},
pages = {640--642},
doi = {10.1016/j.mencom.2019.11.011}
}
MLA
Cite this
MLA Copy
Rukk, Nataliya Samuilovna, et al. “Synthesis, structure and cytotoxicity of a zinc(II) bromide complex with caffeine.” Mendeleev Communications, vol. 29, no. 6, Nov. 2019, pp. 640-642. https://mendcomm.colab.ws/publications/10.1016/j.mencom.2019.11.011.

Abstract

The synthesis and structure of a zinc(II) bromide complex with caffeine (caf), [Zn(caf)(H2O)Br2], are described in comparison with [Zn(caf)(H2O)X2] (X=Cl, I) complexes. Data on the cytotoxicity of [Zn(caf)(H2O)X2] (X=Cl, Br, I) towards human tumor cell lines are presented. The bromo complex has some advantages over chloro and iodo complexes for cytotoxicity on MCF-7 breast cancer cell line, and it is comparable to the chloro complex in cytotoxicity for Jurkat human T cell leukemia.

References

2.
Metal complexes in cancer therapy – an update from drug design perspective
Ndagi U., Mhlongo N., Soliman M.
Drug Design, Development and Therapy, 2017
3.
Transition Metal Intercalators as Anticancer Agents—Recent Advances
Deo K., Pages B., Ang D., Gordon C., Aldrich-Wright J.
International Journal of Molecular Sciences, 2016
5.
Synthesis, X-ray crystal structure and cytotoxicity studies of lanthanide(III) iodide complexes with antipyrine
Rukk N.S., Albov D.V., Shamsiev R.S., Mudretsova S.N., Davydova G.A., Sadikov G.G., Antsyshkina A.S., Kravchenko V.V., Skryabina A.Y., Apryshko G.N., Zamalyutin V.V., Mironova E.A.
Polyhedron, 2012
6.
Anticancer evaluation of ruthenium(III) complexes with N-donor ligands tethered to coumarin or uracil moieties
Gramni L., Vukea N., Chakraborty A., Samson W.J., Dingle L.M., Xulu B., de la Mare J., Edkins A.L., Booysen I.N.
Inorganica Chimica Acta, 2019
9.
10.1016/j.mencom.2019.11.011_bib0045
Rumyantseva
Tonkie Khim. Tekhnol., 2017
11.
Chitturi R., Baddam V.R., Prasad L., Prashanth L., Kattapagari K.
Journal of Dr NTR University of Health Sciences, 2015
12.
Synthesis, X-ray crystal structure and cytotoxicity studies of zinc(II) and cadmium(II) iodide complexes with antipyrine
Rukk N.S., Kuzmina L.G., Albov D.V., Shamsiev R.S., Mudretsova S.N., Davydova G.A., Retivov V.M., Volkov P.A., Kravchenko V.V., Apryshko G.N., Streletskii A.N., Skryabina A.Y., Mironova E.A., Zamalyutin V.V.
Polyhedron, 2015
13.
Non-classical anticancer agents: synthesis and biological evaluation of zinc(ii) heteroleptic complexes
Liguori P.F., Valentini A., Palma M., Bellusci A., Bernardini S., Ghedini M., Panno M.L., Pettinari C., Marchetti F., Crispini A., Pucci D.
Dalton Transactions, 2010
14.
Zn(II), Cd(II) and Hg(II) metal complexes of 2-aminonicotinaldehyde: Synthesis, crystal structure, biological evaluation and molecular docking study
Mallela R., Konakanchi R., Guda R., Munirathinam N., Gandamalla D., Yellu N.R., Kotha L.R.
Inorganica Chimica Acta, 2018
15.
10.1016/j.mencom.2019.11.011_bib0075
El-Tabl
Bioinorg. Chem. Appl., 2015
16.
10.1016/j.mencom.2019.11.011_bib0080
Vartanyan
Psikhofarmakologiya i Biologicheskaya Narkologiya (Psychopharmacol. Biol. Narcol.), 2005
17.
Bio-Medical Aspects of Purine Alkaloids
Melnik M., Sprusansky O., Musil P.
Advances in Biological Chemistry, 2014
18.
Caffeine-Based Gold(I) N-Heterocyclic Carbenes as Possible Anticancer Agents: Synthesis and Biological Properties
Bertrand B., Stefan L., Pirrotta M., Monchaud D., Bodio E., Richard P., Le Gendre P., Warmerdam E., de Jager M.H., Groothuis G.M., Picquet M., Casini A.
Inorganic Chemistry, 2014
19.
A multi-target caffeine derived rhodium(i) N-heterocyclic carbene complex: evaluation of the mechanism of action
Zhang J., Muenzner J.K., Abu el Maaty M.A., Karge B., Schobert R., Wölfl S., Ott I.
Dalton Transactions, 2016
20.
Zinc(II) and cadmium(II) halide complexes with caffeine: Synthesis, X-ray crystal structure, cytotoxicity and genotoxicity studies
Rukk N.S., Kuzmina L.G., Shamsiev R.S., Davydova G.A., Mironova E.A., Ermakov A.M., Buzanov G.A., Skryabina A.Y., Streletskii A.N., Vorob'eva G.A., Retivov V.M., Volkov P.A., Belus S.K., Kozhukhova E.I., Krasnoperova V.N., et. al.
Inorganica Chimica Acta, 2019
21.
SAINT, v. 6.02a, Bruker AXS Inc., Madison, WI, USA, 2001.
22.
OLEX2: a complete structure solution, refinement and analysis program
Dolomanov O.V., Bourhis L.J., Gildea R.J., Howard J.A., Puschmann H.
Journal of Applied Crystallography, 2009
23.
SHELXTL-Plus, v. 5.10, Bruker AXS Inc., Madison, WI, USA, 1997.
24.
Mercury CSD 2.0– new features for the visualization and investigation of crystal structures
Macrae C.F., Bruno I.J., Chisholm J.A., Edgington P.R., McCabe P., Pidcock E., Rodriguez-Monge L., Taylor R., van de Streek J., Wood P.A.
Journal of Applied Crystallography, 2008
25.
A. N. Mironov, Metodicheskie rekomendatsii po doklinicheskomu izucheniyu protivoopukholevoi aktivnosti lekarstvennykh sredstv (Methodical Recommendations on Pre-clinical Trials of Antitumor Activity of Drugs), Moscow, Grif and K., 2013, pp. 643linical Russian).
26.
Fluorescence and DNA-binding properties of neodymium(III) and praseodymium(III) complexes containing 1,10-phenanthroline
Khorasani-Motlagh M., Noroozifar M., Mirkazehi-Rigi S.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2011